In patients diagnosed with Duchenne muscular dystrophy, scientists used next-generation genome mapping to identify pathogenic structural variants caused by large deletions, insertions, and inversions disrupting the X-linked dystrophin gene.
Read More
POC testing is unlocking new markets for commercial IVDs, but reaching potential new customers can be a challenge.
Read More
Vantari Genetics and Translational Software have partnered to provide genotype testing, actionable genomic information, and custom reporting in support of the GeneMatch registry at Banner Alzheimer’s Institute.
Read More
Quest Diagnostics has approved a definitive agreement to acquire Cleveland HeartLab, with the intent of establishing a national center of excellence in heart disease diagnostic information services.
Read More
Qiagen and Centogene have entered into a collaboration and comarketing agreement to provide more-complete research and clinical testing solutions for rare genetic diseases.
Read More